Tel Aviv, Israel

Thomas Bayer

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Thomas Bayer

Introduction

Thomas Bayer is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the development of ibandronate sodium and ibandronic acid. With a total of two patents to his name, Bayer's work has had a meaningful impact on medical science.

Latest Patents

Bayer's latest patents include "Solid and crystalline ibandronate sodium and processes for preparation thereof." This invention relates to solid amorphous and crystalline forms of ibandronate sodium. Another significant patent is "Solid and crystalline ibandronic acid," which provides novel crystalline and amorphous forms of ibandronic acid, methods for their preparation, and pharmaceutical compositions containing them. Additionally, this patent includes methods for purifying and assaying ibandronic acid in any crystalline or amorphous form.

Career Highlights

Thomas Bayer is currently associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions in the pharmaceutical sector, contributing to advancements in drug formulation and delivery.

Collaborations

Bayer has collaborated with several talented individuals in his field, including Revital Lifshitz-Liron and Michael Pinchasov. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical innovations.

Conclusion

In summary, Thomas Bayer is a distinguished inventor whose work in the pharmaceutical industry has led to important advancements in drug formulations. His patents on ibandronate sodium and ibandronic acid showcase his commitment to innovation and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…